Veramaris is a 50:50 joint venture of DSM and Evonik for the production of the omega-3 fatty acids EPA and DHA from natural marine algae.
Located in Delft, the Netherlands, Veramaris was launched in 2018, because its parent companies shared a vision: to conserve marine life by using a resource the ocean provides – natural marine microalgae.
Producing an algal oil rich in the two essential omega-3 fatty acids EPA and DHA through large-scale fermentation at its facility in Blair, Nebraska, USA, Veramaris enables partners along the value chain to become independent from wild-caught fish and meet the growing demand for animal protein responsibly.
Umami Bioworks Unlocks High-Value Species for Regenerative Skincare Singapore
Singapore-based biotech leader Umami Bioworks has announced a major expansion of its Marine Radiance™ platform, moving beyond traditional sources to produce cultivated Polydeoxyribonucleotide (P...